LMR Partners’s Celularity CELU Stock Holding History

LMR Partners’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,374	Closed	-$173K	–	1237
2021 Q4	$173K	Buy	+3,374	New	+$216K	﹤0.01%	1088

Other funds holding CELU

SIC

Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return

CVSC

C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return

Palantir Technologies Aventura, Florida $9.72M AUM 6.46% 1-Year Est. Return

LDFO

Louis-Dreyfus Family Office Wilton, Connecticut $64.7M AUM 21.08% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return

LMR Partners's CELU Position: Q1 2022 in Review

LMR Partners sold out of Celularity (CELU) in Q1 2022, closing a stake of 3,374 shares — an estimated $173K sold.

LMR Partners first reported a position in CELU in Q4 2021 and held it in 1 quarter. The position peaked at $173K in Q4 2021. 38 funds tracked by Wall St. Rank hold CELU as of Q1 2022.

LMR Partners reported no remaining Celularity position as of Q1 2022 after selling out during the quarter.
LMR Partners sold 3,374 Celularity shares in Q1 2022, an estimated $173K.
LMR Partners first reported a position in Celularity in Q4 2021 and held it in 1 quarter.
LMR Partners's Celularity position peaked at $173K in Q4 2021.
38 funds tracked by Wall St. Rank held Celularity as of Q1 2022.

Based on LMR Partners's 13F filing for Q1 2022, filed 16 May 2022.